These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23137339)

  • 1. Immunosuppressive properties of a series of novel inhibitors of the monocarboxylate transporter MCT-1.
    Påhlman C; Qi Z; Murray CM; Ferguson D; Bundick RV; Donald DK; Ekberg H
    Transpl Int; 2013 Jan; 26(1):22-9. PubMed ID: 23137339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The specific monocarboxylate transporter-1 (MCT-1) inhibitor, AR-C117977, induces donor-specific suppression, reducing acute and chronic allograft rejection in the rat.
    Ekberg H; Qi Z; Pahlman C; Veress B; Bundick RV; Craggs RI; Holness E; Edwards S; Murray CM; Ferguson D; Kerry PJ; Wilson E; Donald DK
    Transplantation; 2007 Nov; 84(9):1191-9. PubMed ID: 17998876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Operational tolerance in nonvascularized transplant models induced by AR-C117977, a monocarboxylate transporter inhibitor.
    Påhlman C; Malm H; Qi Z; Veress B; Ferguson D; Bundick R; Murray C; Donald D; Ekberg H
    Transplantation; 2008 Oct; 86(8):1135-8. PubMed ID: 18946353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The specific monocarboxylate transporter (MCT1) inhibitor, AR-C117977, a novel immunosuppressant, prolongs allograft survival in the mouse.
    Bueno V; Binet I; Steger U; Bundick R; Ferguson D; Murray C; Donald D; Wood K
    Transplantation; 2007 Nov; 84(9):1204-7. PubMed ID: 17998878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism analysis of long-term graft survival by monocarboxylate transporter-1 inhibition.
    Cho KS; Yamada T; Wynn C; Behanna HA; Hong IC; Manaves V; Nakanishi T; Hirose J; Abe Y; Jiang H; Tamura K; Saita Y
    Transplantation; 2010 Dec; 90(12):1299-306. PubMed ID: 21076380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent blockers of the monocarboxylate transporter MCT1: novel immunomodulatory compounds.
    Guile SD; Bantick JR; Cheshire DR; Cooper ME; Davis AM; Donald DK; Evans R; Eyssade C; Ferguson DD; Hill S; Hutchinson R; Ingall AH; Kingston LP; Martin I; Martin BP; Mohammed RT; Murray C; Perry MW; Reynolds RH; Thorne PV; Wilkinson DJ; Withnall J
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2260-5. PubMed ID: 16455256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of monocarboxylate transport in human kidney HK-2 cells.
    Wang Q; Lu Y; Yuan M; Darling IM; Repasky EA; Morris ME
    Mol Pharm; 2006; 3(6):675-85. PubMed ID: 17140255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted sensitization of tumor cells for radiation through monocarboxylate transporters 1 and 4 inhibition in vitro.
    Brandstetter G; Blatt S; Goldschmitt J; Taylor L; Heymann P; Al-Nawas B; Ziebart T
    Clin Oral Investig; 2021 Jan; 25(1):295-310. PubMed ID: 32495222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocarboxylate transporter MCT1 is a target for immunosuppression.
    Murray CM; Hutchinson R; Bantick JR; Belfield GP; Benjamin AD; Brazma D; Bundick RV; Cook ID; Craggs RI; Edwards S; Evans LR; Harrison R; Holness E; Jackson AP; Jackson CG; Kingston LP; Perry MW; Ross AR; Rugman PA; Sidhu SS; Sullivan M; Taylor-Fishwick DA; Walker PC; Whitehead YM; Wilkinson DJ; Wright A; Donald DK
    Nat Chem Biol; 2005 Dec; 1(7):371-6. PubMed ID: 16370372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of monocarboxylate transporter 1 blockers through analysis and modulation of atropisomer interconversion properties.
    Guile SD; Bantick JR; Cooper ME; Donald DK; Eyssade C; Ingall AH; Lewis RJ; Martin BP; Mohammed RT; Potter TJ; Reynolds RH; St-Gallay SA; Wright AD
    J Med Chem; 2007 Jan; 50(2):254-63. PubMed ID: 17228867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polarized lactate transporter activity and expression in the syncytiotrophoblast of the term human placenta.
    Settle P; Mynett K; Speake P; Champion E; Doughty IM; Sibley CP; D'Souza SW; Glazier J
    Placenta; 2004 Jul; 25(6):496-504. PubMed ID: 15135232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flavonoids modulate monocarboxylate transporter-1-mediated transport of gamma-hydroxybutyrate in vitro and in vivo.
    Wang Q; Morris ME
    Drug Metab Dispos; 2007 Feb; 35(2):201-8. PubMed ID: 17108059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant reduction of acute cardiac allograft rejection by selective janus kinase-1/3 inhibition using R507 and R545.
    Deuse T; Hua X; Taylor V; Stubbendorff M; Baluom M; Chen Y; Park G; Velden J; Streichert T; Reichenspurner H; Robbins RC; Schrepfer S
    Transplantation; 2012 Oct; 94(7):695-702. PubMed ID: 22971540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Novel Silyl Cyanocinnamic Acid Derivatives as Metabolic Plasticity Inhibitors for Cancer Treatment.
    Nelson GL; Ronayne CT; Solano LN; Jonnalagadda SK; Jonnalagadda S; Rumbley J; Holy J; Rose-Hellekant T; Drewes LR; Mereddy VR
    Sci Rep; 2019 Dec; 9(1):18266. PubMed ID: 31797891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular lactate flux: a new regulator of the allogenic immune response.
    Durrbach A; Francois H
    Transpl Int; 2013 Jan; 26(1):20-1. PubMed ID: 23237578
    [No Abstract]   [Full Text] [Related]  

  • 16. A novel indole-3-propanamide exerts its immunosuppressive activity by inhibiting JAK3 in T cells.
    Carbonnelle D; Duflos M; Marchand P; Chauvet C; Petit JY; Lang F
    J Pharmacol Exp Ther; 2009 Nov; 331(2):710-6. PubMed ID: 19710367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effects of RAD and Neoral in inhibition of host-vs.-graft and graft-vs.-host immune responses in rat small-bowel transplantation.
    Johnson S; Qi S; Xu D; Jolicoeur M; Liu D; Barama A; Busque S; Smeesters C; Daloze P; Chen H
    Microsurgery; 2003; 23(5):476-82. PubMed ID: 14558006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The monocarboxylate transporter family--role and regulation.
    Halestrap AP; Wilson MC
    IUBMB Life; 2012 Feb; 64(2):109-19. PubMed ID: 22162139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin graft pretreatment in small bowel and kidney transplantation in the rat.
    Chen H; Xu D; Qi S; Wu J; Luo H; Daloze P
    Transplantation; 1995 Apr; 59(8):1084-9. PubMed ID: 7732551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments of human monocarboxylate transporter (hMCT) inhibitors as anticancer agents.
    Wu P; Zhou Y; Guo Y; Zhang SL; Tam KY
    Drug Discov Today; 2021 Mar; 26(3):836-844. PubMed ID: 33450176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.